Author

admin

Browsing

President Donald Trump on Wednesday signed an executive order ending the de minimis trade loophole for low-value packages shipped from all countries.

The order, which takes effect Aug. 29, will subject any shipments of imported goods into the U.S. worth $800 or less to duties, the White House said.

Any goods shipped through the international postal network will be subject to tariff rates based on the value of the package and its country of origin.

The move comes after Trump in May shuttered the de minimis loophole for goods from China and Hong Kong. A federal trade court on Monday declined to block Trump’s de minimis ban, even after an auto parts retailer argued the action was unlawful and threatened its business.

Use of the de minimis provision has exploded in recent years as online shopping has become more prevalent. Ultra-cheap online retailers such as Temu and Shein have used the loophole to ship packages to American shoppers directly from China duty-free.

Shares of PDD Holdings, the parent company of Temu, dipped lower following the announcement.

The Trump administration has sought to close the loophole, calling it a “big scam” that hurts U.S. businesses. Officials have said de minimis facilitates shipments of fentanyl and other illicit substances, saying the packages are less likely to be inspected by customs agents.

The volume of de minimis shipments has skyrocketed to 309 million units so far this fiscal year, up from 115 million for all of last year, the White House said.

This post appeared first on NBC NEWS

The oldest active player in MLB will have to soon find another team to continue his career.

Left-hander Rich Hill was designated for assignment by the Kansas City Royals, the club announced Tuesday, July 29. The move was made with Kansas City recalling Thomas Hatch from Triple-A Omaha.

The 45-year-old Hill had a short stint with the Royals after signing a minor league contract with the team in May. On July 22, Kansas City called up Hill and started him the same day against the Chicago Cubs, making him the oldest player to appear in MLB this season and oldest ever to play for the Royals. He also became one of just five players over 45 to play in the majors since 2010, and the first to do so since 2018. 

Hill made two starts for Kansas City, giving up seven runs − five earned − on nine hits and eight walks allowed with four strikeouts. He went 0-2 with the Royals.

Rich Hill could make history

While it marks the sudden end of Hill’s time in Kansas City, it presents him with the opportunity to make MLB history if he continues his career.

The Royals marked the 14th team Hill has played for in his 21-year career, which tied retired pitcher Edwin Jackson for the most teams played for in MLB history. If Hill is able to sign with another new team and pitch for it, he would be the first person to play for 15 teams − half of MLB’s squads.

Hill made his MLB debut in 2005 with the Chicago Cubs, and has a 90-76 record with a 4.02 ERA in 388 games played.

What teams has Rich Hill played for?

  • Chicago Cubs (2005-2008)
  • Baltimore Orioles (2009)
  • Boston Red Sox (2010-2012, 2015, 2022, 2024)
  • Cleveland Guardians (2013)
  • Los Angeles Angels (2014)
  • New York Yankees (2014)
  • Athletics (2016)
  • Los Angeles Dodgers (2016-2019)
  • Minnesota Twins (2020)
  • Tampa Bay Rays (2021)
  • New York Mets (2021)
  • Pittsburgh Pirates (2023)
  • San Diego Padres (2023)
  • Kansas City Royals (2025)
This post appeared first on USA TODAY

The NFL’s Manhattan headquarters were targeted by a gunman who killed four people and ‘seriously injured’ an NFL employee during a mass shooting on Monday, July 28.

On Tuesday, July 29, NFL commissioner Roger Goodell sent an email to all of the league’s employees addressing the incident.

‘I want to take a moment to reach out to you all following yesterday’s tragic events,’ Goodell wrote in a letter obtained by USA TODAY Sports. ‘Our hearts go out to all of the victims and their families, and we are deeply grateful for the first responders and medical staff who acted so quickly and continue to provide care.

‘Our thoughts and prayers remain especially with our colleague who was impacted. He is currently surrounded by his family and members of the NFL community, and we are all continuing to hope for and support his full recovery.’

Goodell said in a statement earlier in the day the injured employee was in ‘stable condition,’ but declined to identify him.

Multiple reports identified Craig Clementi as the NFL employee injured in the shooting. Clementi is a member of the league’s finance department.

Goodell also announced the league’s New York office will remain closed through at least Aug. 8. All employees based at that location are instructed to work from home.

The NFL will provide a virtual town hall for its employees on Wednesday, July 30, during which they ‘can connect, share, and support each other.’

‘Thank you to all of you for the compassion, care, and support you are showing to one another right now. It means so much to see how our team is pulling together,’ Goodell wrote.

‘In the midst of this difficult time, we hold on to hope and optimism for healing and brighter days ahead.’

This post appeared first on USA TODAY

Just days from Major League Baseball’s July 31 trade deadline, the market held its collective breath on Monday when Eugenio Suárez was hit by a pitch on the hand and removed from Arizona’s game. But X-rays came back negative on the Diamondbacks slugger, presumed to be the top bat available before Thursday’s 6 p.m. deadline.

The AL Central-leading Tigers added a pair of arms, making an in-division trade with the Minnesota Twins to add right-handers Chris Paddack and Randy Dobnak. Detroit officially lost starter Reece Olson for the season with a shoulder injury earlier in the day Monday.

Here’s a look back at all the news and updates from Tuesday, July 29:

New York Mets trade rumors

It’s been rather evident around the baseball world that the New York Mets have been looking to upgrade their outfield before the trade deadline. The New York Post’s Jon Heyman reports that the Chicago White Sox’s Luis Robert Jr. and the Baltimore Orioles’ Cedric Mullins have been two outfielders the Mets are looking at to fill that hole on their roster.

Robert Jr.’s trade value has been heating up over the last seven games, as he is hitting .280 at the plate with seven hits, six RBIs and a home run in that stretch. According to ESPN’s Buster Olney, it remains unclear if the White Sox will trade their centerfielder away, as they have ‘tons of payroll flexibility moving forward’ next season to carry his $20 million option. However, if they do, the price is expected to be high. — John Leuzzi, USA TODAY Sports

David Bednar trade rumors: Yankees eying Pirates closer

The New York Post’s Jon Heyman reports that the Yankees are looking to improve their bullpen two days away from the trade deadline, and have talked to the Pittsburgh Pirates about their All-Star closer David Bednar, who has become a target of theirs.

Heyman also noted that the Yankees are looking at Pirates starter Mitch Keller. Trading for Bednar would add another lockdown late-inning option for Aaron Boone and the Bronx Bombers to pair with Devin Williams and Luke Weaver. — John Leuzzi, USA TODAY Sports

Jhoan Duran trade rumors: Has Twins closer been traded?

Has one of the top closers on the market been traded? According to ESPN’s Jeff Passan, the answer is no for Minnesota right-handed reliever Jhoan Duran, who was caught on the Twins TV broadcast hugging teammates in the bullpen during the third inning at Target Field with his glove in his hand.

Passan noted that Duran, for now, had not been traded and was ‘just hugging his bullpen catcher’ — got to love trade deadline week (and season). The Twins radio broadcast was the first to mention Duran grabbing his glove and stuff from the bullpen and leaving it. — John Leuzzi, USA TODAY Sports

Wilson Contreras wants to stay with Cardinals

Meeting with reporters ahead of Tuesday’s game vs. the Miami Marlins, St. Louis Cardinals first baseman Willson Contreras told reporters that he recently spoke with Cardinals president of baseball operations John Mozeliak and expressed that he didn’t want to be traded.

‘I’m good here. I’m good here,’ Contreras said. ‘… I don’t think I have done enough for me to leave (St. Louis) yet.’

Contreras is hitting .259 on the season with 14 home runs and 61 RBIs for the Cardinals, who are nine games back of the Milwaukee Brewers in the NL Central. — John Leuzzi, USA TODAY Sports

Yankees looking to upgrade starting rotation

MLB Network’s Jon Morosi reports that the New York Yankees have had talks with the Miami Marlins and Arizona Diamondbacks to improve his team’s starting rotation, and have had talks with the Miami Marlins and Arizona Diamondbacks for that.

As noted by Morosi, both the Marlins and Diamondbacks have several pieces who can fill the Yankees’ rotational needs in Sandy Alcantara (Marlins), Edward Cabrera (Marlins), Zac Gallen (Diamondbacks) and Merrill Kelly (Diamondbacks).

On the Tuesday episode of ‘MLB on TBS: Leadoff,’ Morosi mentioned that Gallen — who has a 7-12 record this season with a 5.60 ERA — and Kelly, who has a 9-6 record and 3.22 ERA, could be more suitable options for the Yankees compared to Alcantara and Cabrera, as the Diamondbacks starters are rentals.

The Yankees are five games back of the Toronto Blue Jays for first place in the AL East. — John Leuzzi, USA TODAY Sports

Blue Jays trade rumors: Toronto eying Ryan Helsley

The Blue Jays reportedly will look to bolster their bullpen following their trade for Baltimore Orioles right-handed reliever Seranthony Dominguez earlier this afternoon: MLB.com’s Mark Feinsand reports Toronto is eying St. Louis Cardinals closer Ryan Helsley.

Helsley, 31, is 3-1 on the season with a 3.00 ERA and 21 saves in 36 innings of work for the Cardinals. — John Leuzzi, USA TODAY Sports

Orioles trade Seranthony Dominguez to Blue Jays – in opposing clubhouse

In between games of the teams’ doubleheader in Baltimore on Tuesday, the Toronto Blue Jays acquired 30-year-old right-handed reliever Seranthony Dominguez from the Orioles, according to multiple reports. The Orioles will receive right-handed pitching prospect Juaron Watts-Brown to complete the trade, Sportsnet and ESPN reported.

In 298 career games with the Philadelphia Phillies (2018-24) and Orioles (2024-25), Dominguez has gone 21-22 with 40 saves, a 3.54 ERA and 335 strikeouts across 285 innings. He did not play in 2020 due to injury. In 2025, Dominguez is 2-3 with two saves and a 3.24 ERA in 43 appearances for the Orioles. He’s struck out 54 batters for a rate of 11.7 strikeouts per nine innings.

Watts-Brown, 23, has split this season between Double-A New Hampshire and High-A Vancouver. He has gone 2-5 with a 3.54 ERA in 19 starts. MLB Pipeline ranked Watts-Brown as Toronto’s No. 10 prospect. — Field Level Media

Eugenio Suárez to Tigers? Gleyber Torres backs a trade

The Tigers are one of many teams interested in acquiring Eugenio Suárez from the Diamondbacks before the MLB trade deadline, set for 6 p.m. Thursday, July 31. Other teams in the mix include the Cincinnati Reds, Chicago Cubs, Milwaukee Brewers, Philadelphia Phillies and Seattle Mariners.

‘If he comes here at some point, it’s going to be awesome,’ said Torres, a former teammates of Suárez with Team Venezuela in the World Baseball Classic. ‘He treats people the right way. He’s easy to talk to. He always wants to help the players. It would be a really, really good addition for us.’

Said Torres: ‘I think he’s a better person than player. I have a really good relationship with him. He is a humble guy, an awesome person. I’ve known him for many years. Our relationship is really good.’

Suárez has said he wants to play for the Tigers. The Tigers signed Suárez out of Venezuela for a $10,000 bonus during the 2008 international signing period. He made his MLB debut with the Tigers in 2014. After 85 games, the Tigers traded Suárez to the Reds. – Evan Petzold, Detroit Free Press

Danny Jansen trade has catcher back in Wisconsin

Not so long ago, members of the Wisconsin Timber Rattlers lived in the home young Danny Jansen shared with his family, just a bike ride away from Fox Cities Stadium in Appleton. In a twist of fate, it was a Timber Rattlers player sent to another organization who brought Jansen back to Wisconsin.

Jansen, 30, joined the Brewers on July 29, one day after Milwaukee consummated a deal with the Tampa Bay Rays in exchange for Class A infielder Jadher Areinamo. The catcher Jansen, an alumnus of Appleton West and part of a former Timber Rattlers host family, now finds himself with his fourth team in the span of a year after getting dealt on back-to-back trade deadlines.

Eugenio Suárez injury update: D’backs slugger out of lineup

Arizona third baseman Eugenio Suárez, considered the top hitter available ahead of Thursday’s deadline, is out of the Diamondbacks lineup Tuesday in Detroit after being hit on the hand by a pitch on Monday night.

X-rays after the game were egative and Suárez told reporters on Tuesday that he also underwent a CT scan and MRI, both coming back clean. Suárez could return to the lineup on Wednesday for what may be his final game in a Diamondbacks uniform.

Suárez has 36 home runs, is tied for the MLB lead with 87 home runs and could become the first player traded in the middle of a 50-homer campaign since Mark McGwire in 1996.

Phillies trade rumors, team needs

The Philadelphia bullpen took a hit when left-handed reliever José Alvarado was suspended for 80 games in May for violating MLB’s PED policy. To help fill the void, the Phils recently signed veteran right-handed reliever David Robertson after he sat out the season following a strong 2024 season with the Texas Rangers. Robertson has spent two other stints with Philadelphia, including during the team’s 2022 World Series run.

Outfield has also been a concern for much of the year with free-agent addition Max Kepler struggling to provide offensive stability. While he has improved at the plate as the summer has progressed, center fielder Brandon Marsh, along with outfielders Nick Castellanos and Johan Rojas, has been inconsistent offensively this season.

Pirates trade rumors: David Bednar, Mitch Keller

The Pittsburgh Pirates have a few impact players who could be moved ahead of the trade deadline including closer David Bednar and starter Mitch Keller.

An All-Star in 2022 and 2023, the 30-year-old Bednar had a miserable 2024 campaign (5.77 ERA in 62 games), but has rounded back into form this year with a 2.37 ERA, including a career-best 12.1 strikeouts per nine innings.

Keller, 29, signed a four-year extension worth $77 million with the Pirates prior to the 2024 season. An All-Star in 2023, Keller has a 3.69 ERA in 22 starts, his best since 2020, but has seen his strikeout rate fall each of the past two seasons.

‘I think we want to be careful about it, because you have pitching depth until you don’t,’ Cherington told reporters. ‘It’s hard to get it back. We’re not anxious to trade pitching.’

Nick Fortes to Rays in trade with Marlins

The Tampa Bay Rays acquired catcher Nick Fortes from the Miami Marlins on Tuesday in exchange for minor league outfielder Matthew Etzel.

Fortes, 28, batted .249 with two home runs and 10 RBIs in 59 games with the Marlins this season. He is a career .225 hitter with 25 homers and 96 RBIs in 363 games since making his debut with Miami in 2021.

Etzel, 23, was ranked as the Rays’ No. 28 prospect by MLB Pipeline.

He batted .230 with five homers, 34 RBIs and 17 stolen bases in 56 games at Double-A Montgomery this season before landing on the injured list on June 22. – Field Level Media

Chris Paddack, Randy Dobnak traded to Twins

The Tigers acquired right-handers Chris Paddack and Randy Dobnak from the Minnesota Twins on Monday, July 28 — just three days before the MLB trade deadline, which is set for 6 p.m. Thursday, July 31. Although Paddack becomes a free agent after 2025, Dobnak has team options for 2026, 2027 and 2028.

Trading for Paddack was sparked by right-hander Reese Olson suffering a right shoulder strain. He has been ruled out for the remainder of the regular season, but there’s still a chance he returns for the postseason.

‘It’s really an unfortunate piece of news for Reese,’ Tigers president of baseball operations Scott Harris said. ‘We really feel for him. But we are excited to strengthen our pitching before the trade deadline, and we’re really excited to add Chris to the mix.’ – Evan Petzold, Detroit Free Press

Yankees rumors: Cam Schlitter a trade deadline candidate?

MLB’s trade deadline, Thursday at 6 p.m., is a looming presence at Yankee Stadium, where Cam Schlittler’s third big-league start showed an unpolished pitcher with plenty of promise.

“He walks out there with a lot of weapons, starting with a high-90s, 100-mph fastball,’’ Yankees manager Aaron Boone said before Monday night’s game against Tampa Bay.

Schlittler impressively flashed that 100-mph fastball against the Rays but also lost his command for a stretch and the Yankees ultimately lost another divisional game. Maybe that won’t mean parting with Yankees’ slugging prospect Spencer Jones, but he’s clearly part of a lot of trade conversations – as are Schlittler and fellow right-handed starter Will Warren.

Eugenio Suárez injury update

USA TODAY Sports’ Bob Nightengale confirmed that Eugenio Suárez underwent X-rays, which came back negative. Diamondbacks manager Torey Lovullo told reporters that Suárez’s left hand and finger were ‘tender to the touch,’ according to The Athletic’s Cody Stavenhagen. Lovullo added that Suárez is day-to-day for now.

‘The good thing right now is we did the X-ray, and it was negative,’ Suárez said after the game. ‘We got more tests to do tomorrow. Right now, it’s painful, obviously.’

Braves add Erick Fedde

With all five members of their opening day rotation now on the injured list, the struggling Atlanta Braves have added a veteran starter. Erick Fedde, who was designated for assignment by the St. Louis Cardinals last week, fills the void in Atlanta’s rotation after Grant Holmes hit the injured list with elbow inflammation. He joins fellow rotation mates Chris Sale, Spencer Schwellenbach, Reynaldo Lopez and A.J. Smith-Shawver on the 60-day IL.

The Braves acquired Fedde (3-10, 5.22 ERA this season) in exchange for a player to be named later or cash considerations.

Yankees trade Carlos Carrasco

Dealing with the pitching-strapped Braves on Monday, the Yankees traded veteran right-hander Carlos Carrasco to Atlanta.

In announcing the trade prior to their Monday night series opener against the Rays at Yankee Stadium, the Yankees said they will receive cash considerations from the Braves.

2025 MLB trade deadline targets

Here’s a list of a handful of players who could potentially be moved at this year’s deadline:

Pitchers:

  • Sandy Alcantara (Marlins)
  • Zac Gallen (Diamondbacks)
  • Merrill Kelly (Diamondbacks)
  • Mitch Keller (Pirates)
  • Andrew Heaney (Pirates)
  • Johan Duran (Twins)
  • Kenley Jansen (Angels)

Position players:

  • Eugenio Suárez (Diamondbacks)
  • Jarren Duran (Red Sox)
  • Luis Robert Jr. (White Sox)
  • Taylor Ward (Angels)
  • Ryan O’Hearn (Orioles)
This post appeared first on USA TODAY

And, on a 97-degree day when the ball was jumping and the Toronto Blue Jays offered up a bullpen game in the opener of a split doubleheader, Baltimore became the first team with four home runs and five sacrifice flies in a single game, coming in a 16-4 throttling of the best team in the American League.

They tied three other teams in recording five sacrifice flies, and the safety parade began early: Tyler O’Neill and Cedric Mullins each cashed in runs on fly balls in the first inning.

Ramon Urias and Mullins repeated the feat in the third inning off Blue Jays starter Easton Lucas, giving them five innings to break the mark.

Trouble is, the deep fly balls they hit kept going over the fence.

O’Neill homered in his fourth consecutive game, Gunnar Henderson clouted another three-run shot, Urias hit a pair out of the yard.

The sacrifice fly record was equalized with one out in the eighth inning, when Jackson Holliday flew out to left field against Blue Jays catcher Ali Sanchez – who did record a strikeout of Alex Jackson on a 35.3-mph eephus pitch earlier in the frame.

Urías did not realize it was a sac fly record until Holliday mentioned it after the game. And his two homers played a huge role in the homer/sac fly oddity. Given that a runner must be on third with zero or no outs, and a deep enough fly ball must follow, it’s almost a mathematical impossibility – unless aided by dreadful pitching – to get many more than five.

‘How many were there? Five?’ Urías asked after the game.

Yep. And four homers, this for a team that’s flailed most of the season, necessitating a trade deadline sell-off, yet has suddenly burst open for 50 runs in its past four games. That period was marked by catcher Adley Rutschman’s return from injury, making the lineup whole for one of the few times this season.

‘We got a group that is healthy,’ says Urías. ‘The boys are feeling good and swinging it well, and feeling good about each other.’

The USA TODAY app gets you to the heart of the news — fastDownload for award-winning coverage, crosswords, audio storytelling, the eNewspaper and more.

This post appeared first on USA TODAY

The NFL world was rocked on the evening of Monday, July 28 when a shooter targeted the league offices, according to New York City mayor, Eric Adams.

A gunman charged into 345 Park Ave., which houses the NFL’s headquarters and other offices for some major financial firms, fatally shooting four, including an NYPD officer. Amid the chaos, an NFL employee was injured.

The employee, identified as Craig Clementi, is in stable condition per The Athletic’s Dianna Russini, the Washington Post and the New York Daily News.

In a memo sent to employees on Monday evening, NFL Commissioner Roger Goodell stated that a member of the league’s staff was seriously injured – although it made no mention of Clementi.

“He is currently in the hospital and in stable condition,’ Goodell wrote. ‘NFL staff are at the hospital and we are supporting his family.’

The commissioner added that ‘all of our employees are otherwise safe and accounted for.’

Here’s what to know about Clementi and his condition.

Who is Craig Clementi?

Clementi works in the finance department at the NFL.

First reported by The Athletic’s Dianna Russini, Clementi was on the phone with fellow NFL colleagues to warn them about the danger and advise them to evacuate.

Russini added that Clementi continued to call colleagues while being transported to the hospital in an ambulance after being struck by a bullet in the back.

Craig Clementi condition

Clementi is in stable condition, according to reports.

His father-in-law, Robert Hunter, told the New York Daily News that Clementi “was on his way home when he got shot.”He “came through the surgery and there was some spinal damage,” but he is “doing well.”

He was wounded in the back by a bullet during the shooting on July 28. The belief is that the bullet may have ricocheted before striking Clementi.

This post appeared first on USA TODAY

As the global push toward electrification accelerates, lithium remains a critical piece of the energy transition.

Continued oversupply remained a persistent headwind for lithium prices through the first half of 2025. Demand for the battery metal jumped 29 percent year-over-year in 2024, fueled by surging electric vehicle sales and rising power needs from sectors like data centers and heavy industry.

Fastmarket’s analysts expect lithium demand to grow 12 percent annually through 2030, supported by structural trends such as renewable energy integration and battery energy storage.

However, a rapid increase in global supply — particularly from China, Australia and South America — has driven prices to multi-year lows, raising concerns about project economics and the sustainability of new production.

Against this backdrop, Canadian lithium stocks are gaining attention as investors look for companies positioned to benefit from long-term demand growth while navigating short-term price pressure.

1. NOA Lithium Brines (TSXV:NOAL)

Year-to-date gain: 58.82 percent
Market cap: C$488.32 million
Share price: C$0.30

NOA is a lithium exploration and development company with three projects in Argentina’s Lithium Triangle region. The company’s flagship Rio Grande project and prospective Arizaro and Salinas Grandes land packages total more than 140,000 hectares.

As NOA works to advance its flagship asset, the company brought on Hatch in April to lead the preliminary economic assessment (PEA).

The PEA will evaluate the project’s economic and development potential with a target production of 20,000 metric tons of lithium carbonate equivalent (LCE) annually, with a scalable plant design that could double capacity to 40,000 metric tons per year.

NOA has also been working to secure a water source in the arid region through a drilling program targeting fresh water. In late June, the company discovered a fresh water source at the project, located near high-grade lithium zones in the project’s northeast area. According to the company, the location means the water source could support future production facilities or evaporation ponds.

The well, drilled to 190 meters in the northern part of the property, is being tested and developed.

Shares of NOA reached a year-to-date high C$0.425 on July 17, 2025.

2. Wealth Minerals (TSXV:WML)

Year-to-date gain: 40 percent
Market cap: C$23.93 million
Share price: C$0.07

Wealth Minerals is focused on the acquisition and development of lithium projects in Chile, including the Yapuckuta project in Chile’s Salar de Atacama, as well as the Kuska Salar and Pabellón projects near the Salar de Ollagüe.

Wealth Minerals’ shares spiked to a year-to-date high of C$0.095 on February 9, 2025, following the company’s acquisition of the Pabellón project.

According to Wealth, Pabellón has been shortlisted by Chile’s Ministry of Mining as a potential site for a Special Lithium Operation Contract based on its geological and environmental suitability. Located in Northern Chile near the Bolivia border, the project spans 7,600 hectares across 26 exploration licenses about 70 kilometers south of the Salar de Ollagüe.

In May, Wealth formed a joint venture with the Quechua Indigenous Community of Ollagüe to advance the Kuska project. The new entity, Kuska Minerals SpA, is 95 percent owned by Wealth and 5 percent by the community, which also holds anti-dilution rights and a seat on the five-member board.

3. Avalon Advanced Materials (TSX:AVL)

Year-to-date gain: 37.5 percent
Market cap: C$38.26 million
Share price: C$0.055

Avalon Advanced Materials is a Canadian mineral development company focusing on integrating the Ontario lithium supply chain. Avalon is developing the Separation Rapids and Snowbank lithium projects near Kenora, Ontario, and the Lilypad lithium-cesium project near Fort Hope, Ontario.

Separation Rapids and Lilypad are part of a 40/60 joint venture between Avalon and SCR Sibelco, with Sibelco serving as the operator.

Avalon started the year with a revised mineral resource estimate for the Separation Rapids project, which boosted resources in the measured and indicated category by 28 percent.

Company shares rose to C$0.07, a year-to-date high, on July 15, the day after Avalon released its results for its fiscal quarter ended May 31.

A week later, Avalon announced an additional C$1.3 million in funding through its C$15 million convertible security agreement with Lind Global Fund II. The drawdown, expected to close within two weeks, will support project development and general corporate needs, according to the company.

4. Frontier Lithium (TSXV:FL)

Year-to-date gain: 20 percent
Market cap: C$125.41 million
Share price: C$0.54

Pre-production mining company Frontier Lithium aims to be a strategic and integrated supplier of premium spodumene concentrates as well as battery-grade lithium salts in North America.

The company’s flagship PAK lithium project, which is a joint venture with Mitsubishi (TSE:8058), holds the “largest land position and resource” in a premium lithium mineral district located in the Great Lakes region of Ontario, Canada. Frontier also owns the Spark deposit, located northwest of the PAK project.

Shares of Frontier Lithium reached a year-to-date high of C$0.79 on March 4. The stock uptick coincided with a government release reporting the federal and provincial governments supported the company’s plans to build a critical minerals refinery in Northern Ontario.

Once complete, the proposed lithium conversion facility will process lithium from the PAK mine project into approximately 20,000 metric tons of lithium salts per year.

In late May, Frontier released a definitive feasibility study for the mine and mill segment of its PAK project. The study outlines a 31 year mine life with average production of 200,000 metric tons of spodumene concentrate. As for the economics, it projects net revenue of C$11 billion, an after-tax NPV of C$932 million and a 17.9 percent internal rate of return.

5. Century Lithium (TSXV:LCE)

Year-to-date gain: 17.31 percent
Market cap: C$51.58 million
Share price: C$0.30

US-focused Century Lithium is currently advancing its Angel Island lithium project in Esmeralda County, Nevada. The company is also engaged in the pilot testing phase at its on-site lithium extraction facility, which will process material from the lithium-bearing claystone deposit.

On May 6, Century Lithium announced the successful completion of testwork on the direct lithium extraction (DLE) process at its demonstration plant.

The results exceeded expectations, showing 91.6 percent lithium recovery and an eluate grade of 575 milligrams per liter (mg/L) from a 328 mg/L lithium concentrate feed. The company says these improvements could significantly reduce capital and operating costs at its Angel Island project.

Shares of Century Lithium registered a year-to-date high of C$0.49 on May 19.

Recently, the company participated in First Phosphate’s (CSE:PHOS,OTCQB:FRSPF) successful production of commercial-grade lithium iron phosphate (LFP) 18650 battery cells.

As noted in the press release, the cells were made using North America-sourced materials, including lithium carbonate from Century’s Angel Island project in Nevada that was processed at its demonstration plant alongside high-purity phosphoric acid and iron from First Phosphate’s Bégin-Lamarche project in Québec, Canada.

Securities Disclosure: I, Georgia Williams, hold no direct investment interest in any company mentioned in this article.

This post appeared first on investingnews.com

“Whatever is out of favor and hated at the moment, that’s probably what you need to buy,” he said. “Buy it when it’s boring and no one cares, then you get to ride the wave up.”

Barton also broke down his current portfolio, which holds a 30 percent weighting in precious metals—particularly gold—citing concerns over currency policies and the long-term upside for gold and silver.

Watch the interview above for more from Barton on the similarities between poker and resource investing.

Securities Disclosure: I, Georgia Williams, hold no direct investment interest in any company mentioned in this article.

This post appeared first on investingnews.com

From established players to up-and-coming firms, Canada’s pharmaceutical company landscape is diverse and dynamic.

Canadian drug companies are working to discover and develop major innovations amidst an increasingly competitive global landscape. Rising technologies such as artificial intelligence are playing a role in the landscape as well.

Read on to learn about what’s been driving the share prices of the best-performing Canadian pharma stocks.

1. Cipher Pharmaceuticals (TSX:CPH,OTC:CPHRF)

Year-over-year gain: 48.2 percent
Market cap: C$330.79 million
Share price: C$12.33

Cipher Pharmaceuticals is a specialty pharma company with a diverse portfolio of treatments, including a range of dermatology and acute hospital care products. The company has out-licensed some of its offerings as well. Cipher began trading on the OTCQX Best Market under the symbol CPHRF in early 2024.

In addition to its current portfolio, Cipher has acquired Canadian rights to CF-101, a dermatology treatment for moderate to severe plaque psoriasis is currently expected to undergo Phase III clinical trials. The company is also conducting proof-of-concept studies on DTR-001, a topical treatment for removing tattoos.

In 2024, Cipher announced it had signed a definitive asset purchase agreement with ParaPRO for its US-based Natroba operations and global product rights, and the news caused Cipher’s share price to spike significantly.

During its Q1 results reporting in May 2025, the company announced a US$15 million debt repayment.

2. HLS Therapeutics (TSX:HLS)

Year-over-year gain: 42.03 percent
Market cap: C$154.95 million
Share price: C$4.90

HLS Therapeutics focuses on drugs for cardiovascular and central nervous system problems, often through partnerships. The company specializes in acquiring and commercializing pharmaceuticals that address unmet needs. Key commercial products include Vascepa, Clozaril for treatment-resistant schizophrenia and cholesterol-lowering therapies NEXLETOL and NEXLIZET.

Additionally, the company generates revenue from a diversified portfolio of royalty interests on various products marketed by third parties.

3. Medexus Pharmaceuticals (TSX:MDP,OTC:MEDXF)

Year-over-year gain: 23.25 percent
Market cap: C$92.9 million
Share price: C$2.81

Medexus Pharmaceuticals specializes in bringing drugs to treat rare diseases to North America. The company manages the entire process through its fully integrated operations, from acquiring and developing drugs to marketing and selling them. Some of its key products include treatments for hemophilia B and rheumatoid arthritis, as well as a line of drugs for autoimmune diseases like lupus and allergy treatments.

In November 2024, Medexus Pharmaceuticals announced it had successfully negotiated with the pan-Canadian Pharmaceutical Alliance to make treosulfan, which Medexus commercialized in Canada under the name Trecondyv, available to publicly funded drug programs and patients. Trecondyv is indicated as part of conditioning treatment prior to bone marrow transplants in patients with certain types of blood cancers.

In addition to Canada, Medexus has the exclusive commercialization rights to treosulfan in the US, where it received approval from the US Food and Drug Administration (FDA) in January 2025.

4. Satellos Bioscience (TSXV:MSCL,OTC:MSCLF)

Year-over-year gain: 18 percent
Market cap: C$102.26 million
Share price: C$0.59

Satellos Bioscience is a Canadian pharmaceutical company expanding treatment options for muscle disorders. The company has focused specifically on Duchenne muscular dystrophy, developing therapies to regenerate and repair muscle tissue by targeting the specific biological pathways involved. Its lead candidate SAT-3247 targets a protein called AAK1, which regulates the activity of stem cells that activate and differentiate new muscle fibers.

The company began enrolment for a multiple-ascending-dose arm of the Phase 1 study for SAT-3247 last November after no drug-related adverse events were reported in the single-ascending-dose group.

In May of this year, Satellos announced results from its Phase 1b trial, reporting SAT-3247 has shown positive safety and pharmacokinetic data and encouraging early functional results, clearing the path for a planned Phase 2 trial.

5. NurExone Biologic (TSXV:NRX,OTC:NRXBF)

Year-over-year gain: 1.41 percent
Market cap: C$44.18 million
Share price: C$0.72

NurExone Biologic is the biopharmaceutical company behind ExoTherapy, a drug delivery platform that uses exosomes, which are nano-sized extracellular vesicles, to create treatments for central nervous system disorders, spinal cord injuries and traumatic brain injuries. It is a less invasive alternative to cell transplantation, which requires surgery and carries the risk of rejection.

NurExone’s first nano-drug, ExoPTEN, uses a proprietary sIRNA sequence delivered with the ExoTherapy platform to treat spinal cord injuries. ExoPTEN received orphan drug designation from the US Food and Drug Administration (FDA) in October 2023, meaning it has been recognized as a potential treatment for rare medical conditions. The designation makes it eligible for incentives such as market exclusivity and regulatory assistance aimed at accelerating its development and approval.

The company released preclinical results from animal testing evaluating the efficacy of its nano-drug ExoPTEN in restoring lost vision at the end of 2024. In July 2025, preclinical studies indicated that ExoPTEN could improve walking quality in patients with spinal cord injuries.

Securities Disclosure: I, Meagen Seatter, hold no direct investment interest in any company mentioned in this article.

This post appeared first on investingnews.com

Investor Insight

With high-quality, drill-ready assets with world-class discovery potential, Piche Resources is a compelling business case for investors looking to leverage a bull market for uranium and gold.

Overview

Piche Resources (ASX:PR2) is an ASX-listed mineral exploration company focused on uranium and gold exploration in Tier-1 jurisdictions: Western Australia and Argentina. The company holds 100 percent ownership of all of its projects and is supported by a highly experienced board and technical team.

Targeting globally significant discoveries in Tier-1 mineral provinces

Piche’s portfolio includes the advanced-stage Ashburton uranium project in Western Australia and two large-scale exploration projects in Argentina: the Cerro Chacon gold-silver project and the Sierra Cuadrada uranium project. These projects have delivered high-grade exploration results and are drill-ready, positioning the company to unlock significant shareholder value through systematic exploration programmes.

Piche has an internationally recognized board focused on creating long-term shareholder value, and an in-country technical team in Argentina with a proven track record of taking projects from discovery through to development.

Company Highlights

  • Flagship Ashburton uranium project in Western Australia with recent high-grade drilling results over wide intercepts.
  • Sierra Cuadrada uranium project in Argentina showing extensive near-surface mineralisation with assays up to 2.86 percent U₃O₈.
  • Cerro Chacon gold-silver project with high-grade surface results (up to 11.65 g/t gold and 333.7 g/t silver) across a 14 km mineralised corridor.
  • Fully permitted and EIA-approved for drilling at Cerro Chacon (Chacon South and Middle).
  • Large, 100-percent-owned tenement package across all projects (Ashburton: 335 sq km; Cerro Chacon: 414 sq km; Sierra Cuadrada: 1,310 km²).
  • Board of directors includes former leaders of Peninsula Energy, Orano, Rio Tinto Uranium and Barrick Gold.
  • Upcoming drill campaigns planned at Cerro Chacon and Ashburton to test multiple high-priority targets.

Key Projects

Gold: Cerro Chacon, Argentina

Cerro Chacon interpreted geology and tenement holding

Cerro Chacon is a large-scale, early-stage gold-silver exploration project located in the Chubut Province of Argentina. The project is situated within a region known for hosting world-class low-sulphidation epithermal systems, including Cerro Negro and Cerro Vanguardia. With multiple gold-bearing structures confirmed over a 14 km corridor, Cerro Chacon is emerging as a highly promising and underexplored precious metals system with substantial scale and grade potential.

Project Highlights

Location: ~40 km southwest of Paso de Indios, Chubut Province

Tenure: 414 sq km across multiple tenements

Highlights:

  • A 14 km-long mineralised corridor has been delineated across Chacon Grid, La Javiela and Toro Hosco prospects.
  • High-grade geochemical results include:
    • 11.65 g/t gold and 120.3 g/t silver at Toro Hosco
    • 333.7 g/t silver, 9.48 percent lead, and 8.57 percent zinc at La Javiela South
  • Maiden RC drilling programme of 57 holes (7,905 m) scheduled across three main targets:
    • Chacon Grid: 45 holes (5,590 m)
    • La Javiela: 8 holes (1,740 m)
    • Toro Hosco: 4 holes (575 m)
  • EIA approvals for Chacon South and Chacon Middle were received in May 2025, enabling drilling to proceed.
  • Vein systems range from 2 to 6 km in strike length and up to 50 m in width; hosted within structurally controlled low-sulphidation epithermal veins (LSEV).

Uranium: Ashburton Project, Australia

The Ashburton project is Piche’s flagship uranium exploration asset in Australia, situated in the Pilbara region of Western Australia. Located within a historically underexplored but highly prospective unconformity-related uranium district, the project provides the company with strong leverage to the growing global demand for uranium. The project is geologically analogous to world-class Proterozoic uranium systems, with multiple confirmed mineralised zones and a regional corridor of 60 km.

Project Highlights

  • Location: Pilbara region, ~1,150 km north of Perth
  • Tenure: 335 sq km following the recent application for tenement E52/4461 (214 sq km), adding to the existing 122 sq km holdings.
  • Highlights:
    • 2024 RC and diamond drilling confirmed high-grade uranium mineralisation at multiple stratigraphic levels.
    • Best intercepts include:
      • 3.45 m @ 5,129 ppm eU₃O₈ from 137.62 m (ARC006)
      • 10.48 m @ 1,412 ppm eU₃O₈ from 114.30 m (ADD005)
      • 2.42 m @ 2,681 ppm eU₃O₈ from 155.10 m (ADD003).
      • 7.86 m @ 2,266 ppm eU₃O₈ from 105.42 m (ADD006)
    • The company has outlined a 60 km structural corridor hosting multiple uranium occurrences including Angelo A & B, Canyon Creek, Ristretto and Atlantis.
    • Atlantis prospect: historical drilling returned up to 7,400 ppm U₃O₈ over 2.2 m; rock chip samples have returned up to 37 percent U₃O₈.

Uranium: Sierra Cuadrada, Argentina

Sierra Cuadrada is Piche’s primary uranium asset in Argentina, covering a vast area within the San Jorge Basin. This large-scale project has demonstrated strong surface uranium mineralisation with multiple drill-ready prospects. With mineralisation confirmed across extensive zones and supported by historical radiometric and geochemical data, Sierra Cuadrada has the potential to host multiple Tier-1 uranium deposits in a cost-effective, near-surface setting.

Teo 5 and 6 prospect 2024 auger drill programme

Project Highlights:

Location: San Jorge Basin, ~200 km north of Comodoro Rivadavia

Tenure: 1,310 sq km across multiple licences

Highlights:

  • The project area contains broad, flat-lying mineralisation at multiple stratigraphic levels.
  • High-grade uranium assays include:
    • 28,650 ppm U₃O₈ (2.86 percent) from rock chip sampling at Teo 8
    • 24,017 ppm U₃O₈ from channel sampling
    • 2,772 ppm U₃O₈ over 0.5m from auger drill sample
  • Mineralised zones extend over a strike of 60 sq km, with confirmed targets on the majority of tenements.
  • 2024 auger drilling and sampling confirmed uranium continuity across a sandstone and conglomerate sedimentary package with 14 samples exceeding 200 ppm U₃O₈.
  • Rock chip sampling has returned 114 samples >200ppm U₃O₈
  • RC drilling is planned to follow up on anomalies identified in the auger and channel sampling programmes.

Management Team

John (Gus) Simpson – Executive Chairman

John Simpson has over 37 years of experience in mineral exploration, development and mining. Previously the executive chairman and founder of Peninsula Energy Limited (ASX:PEN), a USA uranium producer.

Stephen Mann – Managing Director

Stephen Mann is a geologist with over 40 years of experience in exploration, discovery and development of mining projects, including 20 years in the uranium sector. Formerly the Australian managing director of Orano, the world’s third-largest uranium producer.

Pablo Marcet –Executive Director

Pablo Marcet is a senior geoscientist with 38 years of experience in exploration, discovery and development of mineral deposits. Currently an independent director of lithium producer Arcadium Lithium (NYSE:ALTM) and previously a director of Barrick Gold (NYSE:GOLD) and U3O8 (TSX:UWE).

Clark Beyer – Non-executive Director

Clark Beyer is an internationally recognized nuclear industry executive with over 35 years of experience. Formerly the managing director of Rio Tinto Uranium and currently principal of Global Fuel Solutions, providing strategic consulting to the international uranium and nuclear fuels market.

Stanley Macdonald – Non-executive Director

Stanley Macdonald is a nationally recognized mining entrepreneur, founding director and instrumental in the success of numerous ASX-listed companies, such as Giralia Resources, Northern Star and Redhill Iron. He is currently a director of Zenith Minerals.

This post appeared first on investingnews.com